Back Mojsov, Svetlana emails to Lara Marks, Dec 2024, March 2025
After nearly 4 years of follow-up, investigators found no increased risk of thyroid cancer compared to patients receiving other diabetes medications
Here's a side-by-side comparison: Retatrutide Clinical trials have shown weight reductions of up to 24.2% over 48 weeks with retatrutide
Too much alcohol can raise cholesterol and triglycerides as well as contribute to weight gain
Risk of bias was graded as unclear, high, or low
When applying the filters for income, 56% of the patients taking a GLP-1 had income under $40,000, thus showing that patients in lower socio-economic classes can receive the medication if clinical criteria are met